Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

NCT00095147 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

431

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Abatacept (ABA) + Methotrexate (MTX), double-blind (DB)
DRUG: Infliximab (INF) + MTX, DB
DRUG: Placebo (PLA) + MTX, DB
DRUG: PLA + MTX switched to ABA+ MTX, DB
DRUG: ABA, open-label (OL)

Sponsor

Bristol-Myers Squibb